21920

Incisional biopsy of superficial soft tissue in the back or flank region to obtain a tissue sample for pathologic analysis.

Verified May 8, 2026 · 6 sources ↓

Medicare: $263.87
Work RVU: 2.06
Global, days: 10
Region: Spine

Drawn from CMSAAPCFindacodeGenhealthArgonmedical

Documentation requirements

What must appear in the operative or office note to support the claim.

Source · Editorial brief grounded in 6 cited references ↓

Explicit documentation of tissue depth — superficial (above deep fascia) vs. deep — to justify 21920 over 21925
Location specificity: back vs. flank, and laterality if applicable
Clinical indication for biopsy — mass characteristics, duration, imaging correlation, or suspicion of malignancy
Description of surgical technique: incision type, method of tissue sampling, and closure used
Specimen submission confirmation — pathology requisition or lab order linking specimen to this procedure
Pre-procedure imaging or prior workup referenced in the operative note to establish medical necessity

Applicable modifiers

Modifiers commonly billed with this code.

Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual

22 Increased complexity 50 Bilateral procedure 51 Multiple procedures 52 Reduced services 59 Distinct service LT Left side RT Right side 80 Assistant surgeon AS PA/NP/CNS assistant

What this code covers

Source · Editorial summary grounded in 6 cited references ↓

CPT 21920 covers an open incisional biopsy of superficial soft tissue located in the back or flank. The surgeon excises a tissue sample from the subcutaneous layer — above the deep fascia — for pathologic examination. Typical indications include unexplained masses, suspected neoplasm, chronic infections, or non-healing lesions in the back or flank that require histologic confirmation.

Depth is the critical selector between 21920 (superficial) and 21925 (deep). If the biopsy penetrates the deep fascia, 21925 applies. Coding the wrong depth is the single most auditable error on this pair. Document explicitly whether the lesion was above or below the fascia — 'superficial mass, back' is not sufficient; note fascial layer relationship directly.

The global period is 10 days. Routine wound checks within that window are not separately billable. The HOPD and ASC payment differential is substantial; see the Site of Service comparison. Dermatology and Plastic/Reconstructive Surgery account for the largest Medicare utilization volumes according to CMS Physician Data, though orthopedic and general surgeons bill this code as well.

RVU & reimbursement

Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.

Source · CMS Physician Fee Schedule, RVU26A · January 2026

Work RVU vs. total RVU

The work RVU (2.06) is the surgeon's own effort — the figure physician pay and productivity targets are built on. The total RVU (7.9) adds practice overhead and malpractice, and is what drives the Medicare payment below.

Work RVU	2.06
Practice expense RVU	5.54
Malpractice RVU	0.3
Total RVU	7.9
Medicare national rate	$263.87
Global period	10 days

Payment by site of service

Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.

Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026

Setting	Medicare rate (national)
Office (PFS non-facility) Procedure performed in physician's office	$263.87
HOPD (APC 5072) Hospital outpatient department	$1,687.37
ASC (PI P3) Ambulatory surgical center (freestanding)	$185.96

Common denial reasons

The recurring reasons claims for CPT 21920 get rejected.

Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓

Depth not documented — payer cannot distinguish 21920 (superficial) from 21925 (deep), resulting in downcoding or denial
Medical necessity not established — no documented clinical indication, imaging, or prior workup supporting biopsy over observation
Billed as 21920 when a punch or shave biopsy was actually performed — those route to 11100-series skin biopsy codes, not soft tissue
Missing or mismatched pathology report — payers audit for specimen submission; a biopsy code without a corresponding path report is a red flag
Unbundling error when wound closure is separately billed — simple closure is included in the biopsy

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01What separates 21920 from 21925?

Depth relative to the deep fascia. 21920 is superficial — tissue above the fascia. 21925 is deep — tissue at or below the fascia. Document the fascial relationship explicitly in the operative note; 'superficial mass' alone is not enough.

02Can I bill 21920 for a punch biopsy of the back?

No. Punch biopsies of the skin route to the 11100-series skin biopsy codes. 21920 is for an incisional open biopsy of subcutaneous soft tissue. If the lesion is within the dermis or epidermis, use 11102 or 11104 depending on technique.

03Is wound closure separately billable with 21920?

Simple closure is included — do not bill it separately. If the closure required significant additional work (e.g., layered repair of a complex wound), modifier 22 with supporting documentation is the correct path, not a separate closure code.

04What modifier applies if biopsies are taken from both sides of the back in the same session?

Bill 21920-50 for a bilateral procedure, or 21920-LT and 21920-RT if the sites are distinct and separate lesions on opposite sides. Confirm your payer's preference — some commercial plans want LT/RT instead of 50.

05Does the 10-day global period restrict billing for the pathology results visit?

Yes if the visit is routine follow-up. If the pathology reveals a new finding requiring a separate, unrelated E/M decision — such as counseling on a new malignancy diagnosis — modifier 24 allows that visit to be billed within the global window. Document that the encounter was beyond routine post-op care.

06What ICD-10 codes support medical necessity for 21920?

Common supporting diagnoses include M79.9 (soft tissue disorder, unspecified), D48.1 (neoplasm of uncertain behavior of connective/soft tissue), or a specific benign or malignant mass code when imaging has characterized the lesion. Avoid unspecified codes if imaging or prior workup provides specificity — payers audit biopsy necessity more aggressively when diagnosis codes are vague.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira Scribe

Mira's AI scribe captures depth of dissection relative to the deep fascia, exact anatomic location within the back or flank, lesion characteristics, surgical technique, and specimen disposition directly from dictation. That prevents the most common denial on this code pair — an operative note that describes the procedure without stating whether the biopsy was above or below the fascia, which triggers downcoding or a depth-mismatch audit query.

See how Mira captures CPT 21920 documentation